"Menstrual irregularities in PCOS. Does it matter when it starts?". 2011

S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
Third Department of Medicine, Endocrine Section, University of Athens Medical School, Athens, Greece. sarntis@gmail.com

BACKGROUND PCOS is presented by a broad spectrum of menstrual irregularities appearing often at puberty or later on during the reproductive years in women suffering from this multifaceted syndrome. To our knowledge, there is no evidence to suggest whether the time of onset of menstrual irregularities (peri or post pubertal) indicates a differential metabolic and/or hormonal profile as well as ovarian ultrasonographic findings, in adulthood in women with PCOS. OBJECTIVE To compare anthropometric, hormonal-metabolic profile and ultrasound findings in PCOS women with peripubertal onset of menstrual disorders with the corresponding data obtained from PCOS patients with post pubertal onset of menstrual irregularities, matched for BMI and age. METHODS 89 PCOS women were evaluated cross-sectionally at the age of 25 years. In 49 subjects menstrual irregularities were present from menarche, whereas in 40 women the irregularities appeared at least 3 years post menarche. RESULTS Anthropometric parameters were comparable between the 2 groups. The 2 groups did not differ on metabolic and hormonal profile as well as ovarian ultrasound findings. CONCLUSIONS These data indicate that the timing of menstrual irregularities, do not appear to have an impact, on hormonal/metabolic profile and ovarian ultrasound morphology in patients diagnosed with PCOS, later in life.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006062 Gonadotropins Hormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities. Gonadotropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012739 Gonadal Steroid Hormones Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE. Gonadal Steroid Hormone,Sex Hormone,Sex Steroid Hormone,Sex Steroid Hormones,Sex Hormones,Hormone, Gonadal Steroid,Hormone, Sex,Hormone, Sex Steroid,Hormones, Gonadal Steroid,Hormones, Sex Steroid,Steroid Hormone, Gonadal,Steroid Hormone, Sex,Steroid Hormones, Gonadal,Steroid Hormones, Sex

Related Publications

S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
December 1979, Lancet (London, England),
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
September 2015, American family physician,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
July 2021, Journal of neurology,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
August 2007, Circulation,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
December 2014, Anesthesiology,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
March 2006, Paediatric respiratory reviews,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
July 2004, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
July 2009, Hypertension (Dallas, Tex. : 1979),
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
January 2005, Experimental psychology,
S Livadas, and M Christou, and F Economou, and A Karachalios, and X Xyrafis, and G Boutzios, and A Zerva, and E Tantalaki, and S Palimeri, and E Diamanti-Kandarakis
August 2023, ACS omega,
Copied contents to your clipboard!